Institutional investors purchased a net $651.2 thousand shares of EXAS during the quarter ended September 2017 and now own 83.86% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 1.9 Million shares of Exact Sciences Corp
CARILLON TOWER ADVISERS, INC. Bought 1.3 Million shares of Exact Sciences Corp
CITIGROUP GLOBAL MARKETS, INC. (... Bought 883.7 Thousand shares of Exact Sciences Corp